Management of bladder cancer
- 1 January 1995
- journal article
- Published by Elsevier in Current Problems in Cancer
- Vol. 19 (1) , 5-63
- https://doi.org/10.1016/s0147-0272(07)80002-x
Abstract
No abstract availableKeywords
This publication has 148 references indexed in Scilit:
- Intravesical BCG: Current results, natural history and implicants for urothelial cancer preventionJournal of Cellular Biochemistry, 1992
- M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced carcinoma of the bladderEuropean Journal of Cancer and Clinical Oncology, 1991
- ABO(H) antigens and beta-2 microglobulin in transitional cell carcinoma. Predictors of response to intravesical bacillus calmette-guerinCancer, 1991
- Amplification and expression of the c‐erb B‐2/neu proto‐oncogene in human bladder cancerMolecular Carcinogenesis, 1990
- Neoadjuvant Chemotherapy for Locally Advanced Transitional Cell Carcinoma of the Bladder: Do Local Findings Suggest a Potential for Salvage of the Bladder?Mayo Clinic Proceedings, 1988
- Photodynamic Therapy with Hematoporphyrin Derivative in the Treatment of Superficial Transitional-Cell Carcinoma of the BladderNew England Journal of Medicine, 1987
- Toxicity of intravesical BCG and its management in patients with superficial bladder tumorsCancer, 1987
- The Prevalence of CancerNew England Journal of Medicine, 1986
- Analgesics and cancer of the renal pelvis in New South WalesCancer, 1982
- Epidemiology of urinary bladder cancer: A review of selected literatureJournal of Chronic Diseases, 1966